Injectable Nano-Network for Glucose-Mediated Insulin Delivery
Diabetes mellitus, a disorder of glucose regulation, is a global burden affecting 366 million people across the world. An artificial “closed-loop” system able to mimic pancreas activity and release insulin in response to glucose level changes has the potential to improve patient compliance and healt...
Main Authors: | Gu, Zhen, Aimetti, Alex A., Wang, Qun, Dang, Tram T., Zhang, Yunlong, Veiseh, Omid, Cheng, Hao, Anderson, Daniel Griffith, Langer, Robert S |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
American Chemical Society (ACS)
2014
|
Online Access: | http://hdl.handle.net/1721.1/91254 https://orcid.org/0000-0001-5629-4798 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid–Glucose Complexation
by: Dong, Yizhou, et al.
Published: (2017) -
Microgel encapsulated nanoparticles for glucose-responsive insulin delivery
by: Volpatti, Lisa R, et al.
Published: (2021) -
Engineering synthetically modified insulin for glucose-responsive diabetes therapy
by: Webber, Matthew, et al.
Published: (2019) -
Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles
by: Chen, Delai, et al.
Published: (2017) -
Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery
by: Volpatti, Lisa R, et al.
Published: (2021)